TRUP TRUPANION, INC.
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1371285 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.4%
TTM net income YoY72.2%
TTM EPS YoY69.4%
Revenue 3-yr CAGR13.8%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin1.8%
Net margin1.7%
FCF margin5.6%
EBITDA margin2.8%
Returns
ROE6.9%
ROA3.0%
ROIC (approx.)7.9%
Asset turnover1.73x
Leverage & solvency
Liabilities / assets56.7%
Debt / equity0.26x
Current ratio1.74x
Interest coverage2.90x
Cash quality & payout
Operating cash flow / net income3.59x
Accruals ratio-7.7%
Payout ratio—
Capex / revenue0.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.44B | $1.29B | $1.11B | $905.18M | $698.99M |
| Cost of revenue | $1.21B | $1.11B | $977.59M | $782.99M | $594.64M |
| SG&A expense | $76.65M | $63.73M | $60.21M | $39.38M | $31.89M |
| Operating income | $13.84M | -$9.51M | -$40.66M | -$43.00M | -$35.20M |
| Interest expense | $13.76M | $14.50M | $12.08M | $4.27M | $10,000 |
| Pretax income | $21.99M | -$9.64M | -$45.03M | -$44.20M | -$35.22M |
| Income tax | $2.56M | -$5,000 | -$342,000 | $476,000 | $310,000 |
| Net income | $19.43M | -$9.63M | -$44.69M | -$44.67M | -$35.53M |
| EBITDA | $29.67M | $6.95M | -$28.18M | -$32.08M | -$23.23M |
| EPS (basic) | 0.45 | -0.23 | -1.08 | -1.10 | -0.89 |
| EPS (diluted) | 0.45 | -0.23 | -1.08 | -1.10 | -0.89 |
| Weighted avg. shares (diluted) | 43.56M | 42.16M | 41.44M | 40.77M | 40.14M |
| Balance sheet | |||||
| Cash & equivalents | $138.02M | $199.53M | $170.46M | $84.64M | $100.87M |
| Short-term investments | $232.71M | $147.09M | $129.67M | $156.80M | $126.01M |
| Current assets | $691.06M | $597.33M | $562.09M | $469.10M | $390.95M |
| PP&E, net | $104.84M | $102.19M | $103.65M | $90.70M | $77.95M |
| Goodwill | $39.38M | $36.97M | $43.71M | $41.98M | $32.71M |
| Intangibles | $24.10M | $13.18M | $18.75M | $24.03M | $22.66M |
| Total assets | $915.04M | $806.85M | $782.95M | $671.63M | $562.58M |
| Current liabilities | $409.81M | $349.63M | $344.47M | $289.62M | $223.70M |
| Short-term debt | $10.00M | $1.35M | $1.35M | $1.10M | $0 |
| Long-term debt | $101.78M | $127.54M | $127.58M | $68.35M | $0 |
| Total debt | $111.78M | $128.89M | $128.93M | $69.46M | $0 |
| Total liabilities | $531.11M | $483.58M | $479.23M | $366.33M | $230.38M |
| Shareholders' equity | $383.94M | $323.27M | $303.72M | $305.30M | $332.20M |
| Net debt | -$26.24M | -$70.64M | -$41.53M | -$15.18M | -$100.87M |
| Shares outstanding | 43.40M | 42.49M | 41.86M | 41.01M | 40.48M |
| Cash flow statement | |||||
| Operating cash flow | $89.49M | $48.29M | $18.64M | -$8.00M | $7.46M |
| Capital expenditure | $14.13M | $9.72M | $18.28M | $17.09M | $12.36M |
| Free cash flow | $75.36M | $38.57M | $358,000 | -$25.09M | -$4.90M |
| Investing cash flow | -$95.89M | -$13.46M | $7.64M | -$67.52M | -$51.91M |
| Financing cash flow | -$22.86M | -$3.96M | $59.13M | $60.74M | -$1.12M |
| Depreciation & amortization | $15.84M | $16.47M | $12.47M | $10.92M | $11.96M |
| Stock-based compensation | $38.31M | $33.43M | $33.16M | $33.39M | $28.23M |
| Share buybacks | — | $0 | $0 | $5.75M | $0 |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.